These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17715979)

  • 1. Synthesis of valsartan via decarboxylative biaryl coupling.
    Goossen LJ; Melzer B
    J Org Chem; 2007 Sep; 72(19):7473-6. PubMed ID: 17715979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, pharmacokinetics, and pharmacodynamics studies of valsartan peptide derivatives.
    Wu C; Hu Y; Li Q; He L; Chen J; Cheng Z; Li Y; Hu G
    Arch Pharm (Weinheim); 2012 May; 345(5):393-400. PubMed ID: 22266917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palladium-catalyzed decarboxylative coupling of allylic alkynoates with arynes.
    Pi SF; Tang BX; Li JH; Liu YL; Liang Y
    Org Lett; 2009 Jun; 11(11):2309-12. PubMed ID: 19402675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of angiotensin II receptor blockers by means of a catalytic system for C-H activation.
    Seki M; Nagahama M
    J Org Chem; 2011 Dec; 76(24):10198-206. PubMed ID: 22035509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
    Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
    Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling.
    Su KH; Tsai JY; Kou YR; Chiang AN; Hsiao SH; Wu YL; Hou HH; Pan CC; Shyue SK; Lee TS
    Cardiovasc Res; 2009 Jun; 82(3):468-75. PubMed ID: 19307231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
    Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
    J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting enzyme inhibitor versus valsartan on cellular signaling events in heart transplant.
    White M; Ross H; Levesque S; Whittom L; Pelletier GB; Racine N; Meloche S; Voisin L
    Ann Pharmacother; 2009 May; 43(5):831-9. PubMed ID: 19417110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomeric LC separation of valsartan on amylose based stationary phase.
    Rane V; Patil K; Shinde D
    Pharmazie; 2009 Aug; 64(8):495-8. PubMed ID: 19746836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valsartan and recurrent atrial fibrillation.
    Tomoda H
    N Engl J Med; 2009 Jul; 361(5):532-3; author reply 533. PubMed ID: 19645082
    [No Abstract]   [Full Text] [Related]  

  • 12. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
    He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
    J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stripping voltammetric determination of valsartan in bulk and pharmaceutical products.
    Habib IH; Weshahy SA; Toubar SS; el-Alamin MM
    Pharmazie; 2008 May; 63(5):337-41. PubMed ID: 18557415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
    Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective role of angiotensin II type 2 receptor after transient focal ischemia in mice brain.
    Miyamoto N; Zhang N; Tanaka R; Liu M; Hattori N; Urabe T
    Neurosci Res; 2008 Jul; 61(3):249-56. PubMed ID: 18455256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Valsartan improves symptoms and quality of life in patients with chronic heart failure].
    Baumhäkel M; Müller U
    MMW Fortschr Med; 2008 Dec; 150(49-50):55. PubMed ID: 19133371
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.
    Schmieder RE; Kjeldsen SE; Julius S; McInnes GT; Zanchetti A; Hua TA;
    J Hypertens; 2008 Mar; 26(3):403-11. PubMed ID: 18300848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker.
    Zhu S; Liu Y; Wang L; Meng QH
    Nephrol Dial Transplant; 2008 Sep; 23(9):2841-6. PubMed ID: 18390891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved analytical validation and pharmacokinetics of valsartan using HPLC with UV detection.
    Piao ZZ; Lee ES; Tran HT; Lee BJ
    Arch Pharm Res; 2008 Aug; 31(8):1055-9. PubMed ID: 18787797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits.
    Imanishi T; Ikejima H; Tsujioka H; Kuroi A; Kobayashi K; Shiomi M; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
    Hypertens Res; 2008 Jun; 31(6):1199-208. PubMed ID: 18716369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.